State Street Corp Atara Biotherapeutics, Inc. Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Atara Biotherapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 2,489,048 shares of ATRA stock, worth $19.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,489,048

Previous 2,784,200 10.6%

Holding current value

$19.4 Million

Previous $1.42 Million 21.0%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.44 - $1.22 $129,866 - $360,085	-295,152 Reduced 10.6%	2,489,048 $1.72 Million
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $60,148 - $455,034	261,514 Added 10.37%	2,784,200 $1.42 Million
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $27,320 - $44,758	-19,376 Reduced 0.76%	2,522,686 $3.73 Million
Q2 2023 Aug 14, 2023	SELL	$1.5 - $3.04 $8.54 Million - $17.3 Million	-5,695,411 Reduced 69.14%	2,542,062 $4.09 Million
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $1.65 Million - $3.21 Million	587,733 Added 7.68%	8,237,473 $23.9 Million

Q4 2022 Feb 14, 2023	SELL	$2.85 - $5.18 $1.28 Million - $2.32 Million	-447,613 Reduced 5.53%	7,649,740 $25.1 Million
Q3 2022 Nov 15, 2022	BUY	$2.85 - $8.73 $5.35 Million - $16.4 Million	1,875,667 Added 30.15%	8,097,353 $30.6 Million
Q2 2022 Aug 15, 2022	SELL	$4.69 - $9.84 $243,556 - $511,001	-51,931 Reduced 0.83%	6,221,686 $48.5 Million
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $16.5 Million - $32.9 Million	1,949,418 Added 45.08%	6,273,617 $58.3 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $7.99 Million - $10.8 Million	543,302 Added 14.37%	4,324,199 $68.1 Million
Q3 2021 Nov 15, 2021	SELL	$11.99 - $17.9 $7.09 Million - $10.6 Million	-590,959 Reduced 13.52%	3,780,897 $67.7 Million
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $527,433 - $678,420	-40,918 Reduced 0.93%	4,371,856 $68 Million
Q1 2021 May 17, 2021	BUY	$14.0 - $20.72 $20 Million - $29.6 Million	1,428,333 Added 47.86%	4,412,774 $63.4 Million
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $3.12 Million - $6.47 Million	-246,599 Reduced 7.63%	2,984,441 $58.6 Million
Q3 2020 Nov 10, 2020	SELL	$11.92 - $15.87 $415,030 - $552,561	-34,818 Reduced 1.07%	3,231,040 $41.9 Million
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $7.68 Million - $15.2 Million	1,020,148 Added 45.43%	3,265,858 $47.6 Million
Q1 2020 May 11, 2020	BUY	$5.69 - $17.78 $12.8 Million - $39.9 Million	2,245,710 New	2,245,710 $19.1 Million

Others Institutions Holding ATRA

# of Institutions

Shares Held

85M

Call Options Held

18.4K

Put Options Held

51.3K

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $734M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Atara Biotherapeutics, Inc. Transaction History